NCT00169065View on ClinicalTrials.gov

Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

June 30, 2002

Study Completion Date

June 30, 2002

Conditions
Schizophrenia
Interventions
DRUG

Clozapine

DRUG

Olanzapine

Trial Locations (1)

02130

Commonwealth Research Center, Jamaica Plain

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Dartmouth-Hitchcock Medical Center

OTHER

collaborator

Commonwealth Research Center, Massachusetts

OTHER

collaborator

Eli Lilly and Company

INDUSTRY

lead

Harvard Medical School (HMS and HSDM)

OTHER

NCT00169065 - Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia | Biotech Hunter | Biotech Hunter